Interest in healthy lifestyle and adherence to medications: Impact on mortality among elderly cardiovascular patients in the DEBATE Study

Patient Education and Counseling

Volumn 67, Issue 1-2, 2007, Pages 44-49

  Pitkala, Kaisu H ^a,b   Strandberg, Timo E ^c   Tilvis, Reijo S ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Adherence; Cardiovascular prevention; Elderly; Patient centered consultation; Prognosis

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG USE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; FINLAND; HUMANS; LIFE STYLE; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PATIENT-CENTERED CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS;

EID: 34249946265     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2007.01.016     Document Type: Article

References (33)

1. Haynes R., McDonald H., Garg A., and Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2 (2004) CD000011
2. Jones G. Prescribing and taking medicines. BMJ 327 (2003) 819
3. World Health Organization. Adherence to long-term therapies: evidence for action (2003), World Health Organization
4. Sackett D.L., Haynes R.B., Guyatt G.H., and Tugwell P. Helping patients follow the treatments you prescribe. In: Sackett D.L., Haynes R.B., Guyatt G.H., and Tugwell P. (Eds). Clinical epidemiology (1999), Little, Brown and Company, Boston
5. Stephenson B.J., Rowe B.H., Haynes R.B., Macharia W.M., and Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed?. JAMA 269 (1993) 2779-2781
6. Mead N., and Bower P. Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med 51 (2000) 1087-1110
7. Ferner R.E. Is concordance the primrose path to health?. BMJ 327 (2003) 821-822
8. Strandberg T.E., Pitkala K., Berglind S., Nieminen M.S., and Tilvis R.S. Multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial: Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study. Am Heart J 142 (2001) 945-951
9. Strandberg T.E., Pitkala K., Berglind S., Nieminen M.S., and Tilvis R.S. Possibilities of multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial: Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study. Eur Heart J 24 (2003) 1216-1222
10. Strandberg T.E., Pitkala K., Berglind S., Nieminen M.S., and Tilvis R.S. Multifactorial intervention to prevent recurrent cardiovascular events in patients aged 75 years or older. The DEBATE Study: a randomized controlled trial. Am Heart J 152 (2006) 585-592
11. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., and Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 19 (1998) 1434-1503
12. Stewart M. Towards a global definition of patient centred care. BMJ 322 (2001) 444-445
13. Epstein R.M., Alper B.S., and Quill T.E. Communicating evidence for participatory decision making. JAMA 291 (2004) 2359-2366
14. Epstein R.M. The science of patient-centered care. J Fam Pract 49 (2000) 805-807
15. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
16. Zung W.W.K. A self-rating depression scale. Arch Gen Psychiatr 12 (1965) 63-70
17. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
18. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
19. Strandberg T.E., Salomaa V.V., Naukkarinen V.A., Vanhanen H.T., Sarna S.J., and Miettinen T.A. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 266 (1991) 1225-1229
20. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study Group (4S). Lancet 344 (1994) 1383-1389
21. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.D., Brown L., Warnica J.W., Arnold J.M., Wun C.C., Davis B.R., and Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
22. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., Ford I., Gaw A., Hyland M., Jukema J.W., Kamper A.M., Macfarlane P.W., Meinders A.E., Norrie J., Packard C.J., Perry I.J., Stott D.J., Sweeney B.J., Twomey C., Westendorp RG, and PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
23. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
24. Granger B.B., Swedberg K., Ekman I., Granger C.B., Olofsson B., McMurray J.J., Yusuf S., Michelson E.L., Pfeffer MA, and CHARM investigators. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366 (2005) 2005-2011
25. Keysor J.J., and Jette A.M. Have we oversold the benefit of late-life exercise?. J Gerontol A Biol Sci Med Sci 56 (2001) M412-M423
26. LaCroix A.Z., Guralnik J.M., Berkman L.F., Wallace R.B., and Satterfield S. Maintaining mobility in late life. II. Smoking, alcohol consumption, physical activity, and body mass index. Am J Epidemiol 137 (1993) 858-869
27. Leveille S.G., Guralnik J.M., Ferrucci L., and Langlois J.A. Aging successfully until death in old age: opportunities for increasing active life expectancy. Am J Epidemiol 149 (1999) 654-664
28. Wu S.C., Leu S.Y., and Li C.Y. Incidence of and predictors for chronic disability in activities of daily living among older people in Taiwan. J Am Geriatr Soc 47 (1999) 1082-1086
29. Paffenbarger Jr. R.S., Hyde R.T., Wing A.L., Lee I.M., Jung D.L., and Kampert J.B. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 328 (1993) 538-545
30. Kaplan G.A., Strawbridge W.J., Cohen R.D., and Hungerford L.R. Natural history of leisure-time physical activity and its correlates: associations with mortality from all causes and cardiovascular disease over 28 years. Am J Epidemiol 144 (1996) 793-797
31. Myers J., Prakash M., Froelicher V., Do D., Partington S., and Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346 (2002) 793-801
32. Stuck A.E., Walthert J.M., Nikolaus T., Bula C.J., Hohmann C., and Beck J.C. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 48 (1999) 445-469
33. Tilvis R.S., Pitkala K.H., Jolkkonen J., and Strandberg T.E. Social networks and dementia. Lancet 356 (2000) 77-78